Ildiko Lingvay, MD
Enriched profileProfessor, Department of Internal Medicine, Division of Endocrinology · UT Southwestern Medical Center
Ildiko Lingvay is Professor, Department of Internal Medicine, Division of Endocrinology at UT Southwestern Medical Center. OpenAlex indexes 439 publications with 46,926 citations (h-index 90); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Ildiko Lingvay, MD, is Professor, Department of Internal Medicine, Division of Endocrinology at UT Southwestern Medical Center. The public record shows 439 publications with 46,926 citations (h-index 90), centered on Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 29 companies, 1 NIH-funded awards (2007–2011).
- Most recent indexed publication: 2026 · Diabetes, obesity & metabolism
- Top research focus: Diabetes Treatment and Management
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 29 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 100 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 198.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pmc.ncbi.nlm.nih.gov ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
Sponsor: Boston Scientific Corporation
- DIALYSIS-TIR Study
Sponsor: University of Texas Southwestern Medical Center
Industry payments
Updated 27 Aug 2026
29 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202543 payments$43,817openpaymentsdata.cms.gov ↗
- Novo Nordisk ASProgram year202522 payments$32,016openpaymentsdata.cms.gov ↗
- F. Hoffmann-La Roche AGProgram year20258 payments$18,341openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
55.1%l-Thyroxine55.1%Levothyroxine Sodium68%Synthroid32%Part D<11 patientsMetabolism & gastrointestinal
44.9%SGLT2 inhibitor17%Jardiance100%Part D<11 patientsGLP-1 receptor agonist11.6%Ozempic100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2007–2011 per NIH RePORTER. The latest:
- Role of Pancreatic Triglycerides in Beta-cell Dysfunction
Ut Southwestern Medical Center
FY2011$151,200K23RR024470 - Role of Pancreatic Triglycerides in Beta-cell Dysfunction
Ut Southwestern Medical Center
FY2010$151,200K23RR024470 - Role of Pancreatic Triglycerides in Beta-cell Dysfunction
Ut Southwestern Medical Center
FY2009$151,200K23RR024470
Congress activity
Updated 27 Aug 2026
43 congress contributions (2018–2025) across AACE, ADA, ENDO per OpenAlex. The most recent:
- 2085-LB: Automated Insulin Delivery Systems (AIDs) vs. Multiple Daily Injections (MDI) or Sensor-Augmented Pump Therapy (SAPT) in People with Type 1 Diabetes (T1D) during Pregnancy
ADA Scientific Sessions
ADA2025Co-authorLate-breaking - SAT-572 A Case Of Bilateral Diabetic Muscle Infarction In The Arm And Leg: An Unusual Presentation
ENDO Annual Meeting
ENDO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular-Kidney-Metabolic Syndrome.
Diabetes, obesity & metabolism
Review2026 - Safety of Semaglutide After Dialysis Initiation: An Individual-Level Pooled Analysis.
Diabetes care
Article2026
Most-cited works
by citation count (OpenAlex)- 01Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes6,648 citations2016
- 02Once-Weekly Semaglutide in Adults with Overweight or Obesity4,582 citations2021
- 03Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes2,690 citations2023
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/ildiko-lingvay-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Ildiko-Lingvay
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/lingvay
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- Internal Medicine residency
Texas Tech University Health Sciences Center, Lubbock, TX
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗ - Fellowship
Endocrinology, Diabetes and Metabolism, UT Southwestern Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗ - Board certified
Endocrinology, Diabetes and Metabolism (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗ - Board certified
Obesity Medicine (American Board of Obesity Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗
Editorial & leadership roles
journal and society appointments- Medical Director
Office of Clinical Trials Management, UT Southwestern (institutional oversight of clinical trial approvals)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Secondary affiliations
appointments beyond the home institution- Secondary appointment
Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medscape.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medscape.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →diabetes.medicinematters.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Madhukar Trivedi, MD
UT Southwestern Medical Center
Ambarish Pandey, MD
UT Southwestern Medical Center
Anthony Bavry, MD
UT Southwestern Medical Center
Philip Raskin, MD
UT Southwestern Medical Center